Foresite Capital Management Vi LLC Kymera Therapeutics, Inc. Transaction History
Foresite Capital Management Vi LLC
- $224 Billion
- Q4 2024
A detailed history of Foresite Capital Management Vi LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 146,332 shares of KYMR stock, worth $5.4 Million. This represents 2.62% of its overall portfolio holdings.
Number of Shares
146,332Holding current value
$5.4 Million% of portfolio
2.62%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
185Shares Held
65.5MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$253 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$221 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$196 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$190 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$190 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.02B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...